H. R. Franklin - Concepedia

Author

H. R. Franklin

The Netherlands Cancer Institute

Also Known As

H R Franklin, H R W FRANKLIN, H. R. Franklin, H.R Franklin, H.R. Franklin, HR Franklin

Publications

617

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute European Organisation for Research and Treatment of Cancer Rotterdam University of Applied Sciences

About

H. R. Franklin is an author at The Netherlands Cancer Institute specializing in medicine, dermatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	394
2	Pharmacology	2	2	190
3	Health Sciences	1	1	70
4	Diagnostic Sciences	1	1	70
5	Pathology	1	1	161

H. R. Franklin

Publications

582

Citations

H-Index

Page 1

	Year	Citations
Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG) Thomas Cerny, Steven Kaplan, N. Pavlidis, British Journal of Cancer Non-small-cell Lung CancerPhase Ii TrialMedicineMetronomic TherapyPharmacology	1994	161
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Joost M. Klaase, B.B.R. Kroon, A N van Geel, PubMed	1994	104
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group Steinar Aamdal, Ingmar Wolff, Steven Kaplan, European Journal of Cancer Malignant DiseaseMedicineMelanomaPhase Ii StudyMolecular Oncology	1994	82
Systemic leakage during isolated limb perfusion for melanoma Joost M. Klaase, B.B.R. Kroon, Albertus N. van Geel, British journal of surgery Systemic LeakageSkin CancerMedicineBlood TransfusionMelanoma	1993	70
To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater. H. R. Franklin, H. Schraffordt Koops, J Oldhoff, Journal of Clinical Oncology West GermanySurgical OncologyRetrospective Comparative StudyMedicineMelanoma	1988	52
A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities Joost M. Klaase, B.B.R. Kroon, Alexander Eggermont, European Journal of Cancer Retrospective Comparative StudyHyperthermiaRecurrent MelanomaMelanomaThermal Therapy	1995	47
A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limb Joost M. Klaase, B.B.R. Kroon, H. R. Franklin, Cancer	1993	37
EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents Gilberto Schwartsmann, J. Wanders, I. Koier, European Journal of Cancer and Clinical Oncology Therapeutic Drug MonitoringOncologyMedicineDrug MonitoringPharmacotherapy	1991	29

Page 1